Literature DB >> 3541132

Classification of beta-lactamases.

A Bauernfeind.   

Abstract

Traditionally, the classification of beta-lactamases has followed the general principles of describing enzymes by the characterization of their activity against substrates. New types of beta-lactam structures with therapeutic relevance have emerged, necessitating more specific substrate profiles. Biophysical characterization, i.e., primarily isoelectric focusing, has greatly improved classification, particularly of nonchromosomal beta-lactamases. The classification of beta-lactamases of both gram-positive and gram-negative organisms is reviewed and updated by adding data on recently discovered enzymes. Data on amino acid sequence and molecular structure that are available for an increasing number of beta-lactamases will gradually be incorporated into the established system. In addition, the introduction of evolutionary aspects should serve to modify the existing system, which to date has been based on arbitrarily selected characteristics.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3541132

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  7 in total

Review 1.  Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.

Authors:  E Bergogne-Bérézin; K J Towner
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

Review 2.  The development of beta-lactam antibiotics in response to the evolution of beta-lactamases.

Authors:  S Y Essack
Journal:  Pharm Res       Date:  2001-10       Impact factor: 4.200

3.  Novel R-factor borne beta-lactamase of Escherichia coli confering resistance to cephalosporins.

Authors:  A Bauernfeind; G Hörl
Journal:  Infection       Date:  1987 Jul-Aug       Impact factor: 3.553

4.  In vitro activities of ICI 194008 and ICI 193428, two new cephem antimicrobial agents.

Authors:  J D Allan; G M Eliopoulos; E Reiszner; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

5.  [The role of coagulase negative staphylococci in mixed infections: association testing as an in vitro model].

Authors:  K H Manncke; W R Heizmann
Journal:  Langenbecks Arch Chir       Date:  1989

6.  Efficacy of sulbactam in an in vitro model of mixed aerobic/anaerobic infections.

Authors:  W R Heizmann; F Heilmann; B Egeler; H Werner
Journal:  Infection       Date:  1990 Mar-Apr       Impact factor: 3.553

7.  Enterobacter taylorae, a new opportunistic pathogen: report of four cases.

Authors:  E M Rubinstien; P Klevjer-Anderson; C A Smith; M T Drouin; J E Patterson
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.